Healthy Extracts Sees Impressive Revenue Growth in Q1 2026
Healthy Extracts Inc. has reported a 73% increase in net revenue for Q1 2026, reaching a record $1.6 million, attributed to significant strategic developments.
Topic Intelligence
Articles and insights tagged Biotechnology on FAQSIR.
Healthy Extracts Inc. has reported a 73% increase in net revenue for Q1 2026, reaching a record $1.6 million, attributed to significant strategic developments.
ZEO ScientifiX has announced a significant growth milestone, surpassing $1 million in unaudited monthly sales for the first time in April 2026. This achievement underscores the company's effective sales strategy and commitment to physician partnerships.
Microbix Biosystems Inc. is set to announce its financial results for Q2 fiscal 2026 on May 14, 2026, followed by a webinar featuring discussions with its top executives.
BioLargo's CEO, Dennis P. Calvert, will lead a town hall meeting for shareholders on May 5, 2026, providing company updates and a Q&A session.
BioNxt Solutions Inc. is currently under a Management Cease Trade Order from the BCSC pending the filing of its annual audited financial statements, expected by June 30, 2025.
Aspira Women's Health and Dorsata have officially launched a clinical decision support module that aims to enhance diagnostics for women's health across more than 300 practices.
Numinus Wellness Inc. has initiated the cultivation of Psilocybe mushrooms to produce psilocybin for exploring therapeutic applications in mental health treatment.
Aspira Women's Health has successfully transitioned to the OTCQB marketplace, with CEO Mike Buhle emphasizing the positive implications for shareholders. The company focuses on advancing its AI-driven diagnostic tools for women's health.
AI/ML Innovations Inc. has announced the nomination of Dr. Drew Dundas to its board, increasing the total seats as part of its governance enhancements.